Clayface arrives as a visibly gory, body-horror take on a peripheral figure from the Batman universe, but the novelty of its special effects does not overcome a thin narrative or the sense that it exists primarily to make money from an unfamiliar character.
The film leans heavily into visceral set pieces and practical-CGI effects that emphasise the title character's mutable flesh, and for viewers seeking gross-out spectacle it delivers. Yet critics and audiences may find the rest of the picture undercooked: locations, tone and storytelling feel inconsistent, and Liverpool — the city standing in for Gotham — does not always convince as the grim, iconic metropolis the franchise usually requires.
Context matters. Clayface's release comes at a difficult moment for DC, which, like its competitors, is confronting a cooler marketplace for superhero fare after a decade-plus boom. The broader industry has seen appetite wane, a trend intensified by pandemic-era disruption and a flurry of releases in 2019 that saturated cinemas. While some comic-book titles continue to perform — most notably a summer Spider-Man release that became the biggest film ever in the United States — other recent DC projects have struggled.
Those setbacks include a high-profile Supergirl film that commentators say may have led to heavy losses for Warner Bros, with some estimates of the damage running into the hundreds of millions of dollars; other underperformers have included Black Adam, Joker: Folie à Deux, Blue Beetle and The Flash. Even a widely promoted Superman reboot last year posted a global haul of about $618 million, a solid number but short of the blockbuster heights studios have come to expect.
Against that backdrop, Clayface can be read as part of DC's attempt to find fresh angles — and new revenue — by mining lesser-known corners of its character roster. The result is a film that will satisfy viewers drawn to its shock aesthetics but is unlikely to change the wider calculus for the studio: a visually arresting but narratively limited entry that underscores how difficult it has become for comic-book adaptations to guarantee commercial or critical success.